you will see PPS over $15 before the end of the year. Carl losing $200 Millions ( paper loss) is like you and I lossing $200. he will make that back and millions more after the dust settels.
They have to cover shorts real quick.. see a move upward.
Sentiment: Strong Buy
Any bidding by any company will drive the PPS up. Yes, Canada and US will need to approve the deal. that will take sometimes. but the PPS will be effected as soon as the news is out. BBRY will be sold as a whole or inparts, that will have a positive impact either way. Just the thought of China is intersetd, make BBRY worth buying by others. They see the value. It should be no less than $9 but I see $10-$12.
They can't say anything if there is pending news/buyout. This will end green before the day is over.
Sarissa Capital Management LP, a hedge fund run by investor Carl Icahn's former healthcare lieutenant, has taken a 6.22 percent stake in the wounded biotechnology company Ariad Pharmaceuticals Inc.
This is NOT an American company anyway.
LOSSER, GIVE IT UP , You are like cancer or maybe herpies. just keeps comming back and try harder.
Some day they will get cure for that and you will be gone for ever. for now. suffer watching ELTP moving up.
Not doing well. doing VERY well. it was up 100% from a week ago. If you know the market. it is NEVER straight up line.
Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (ELTP) today announced the initial shipment of naltrexone hydrochloride 50 mg tablets under the License, Manufacturing and Supply Agreement with its sales and marketing partner, triggering a milestone payment. Elite's sales and marketing partner will distribute the product as part of a multi-product distribution agreement.
On September 10, 2012, Epic Investments exercised the remaining Series E Convertible Preferred Stock. Pursuant to the terms of the Series E Convertible Preferred Stock, 65,843,621 shares of common stock were issued to Epic Investments upon the conversion.